You are here

Article Text

Article menu
Download PDFPDF
Ovarian Cancer
Promising Effect of Aromatase Inhibitors on Recurrent Granulosa Cell Tumors
  1. Jacob Korach, MD*,
  2. Tamar Perri, MD*,
  3. Mario Beiner, MD*,
  4. Tima Davidzon, MD†,
  5. Eddie Fridman, MD‡ and
  6. Gilad Ben-Baruch, MD*
  1. *Departments of Gynecologic Oncology,
  2. †Departments of Nuclear Medicine, and
  3. ‡Departments of Pathology, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
  1. Address correspondence and reprint requests to Jacob Korach, MD, Department of Gynecologic Oncology, Sheba Medical Center, 52621 Tel HaShomer, Israel. E-mail: jacobkorach{at}gmail.com.

Abstract

Recurring adult-type granulosa cell tumors of the ovary are usually treated by surgical resection followed by chemotherapy or radiation. However, the results of such treatment are disappointing. We describe 4 patients in whom recurrent ovarian granulosa cell tumors were treated with an aromatase inhibitor, with promising results.

  • Granulosa cell tumor
  • Recurrent
  • Aromatase inhibitor

https://doi.org/10.1111/IGC.0b013e3181a261d7

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.